Last 4.65 MYR
Change Today +0.01 / 0.22%
Volume 2.6K
PHRM On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 3:56 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

pharmaniaga berhad (PHRM) Snapshot

Open
4.69
Previous Close
4.64
Day High
4.69
Day Low
4.65
52 Week High
10/22/13 - 4.99
52 Week Low
03/10/14 - 4.10
Market Cap
1.2B
Average Volume 10 Days
70.7K
EPS TTM
0.26
Shares Outstanding
258.9M
EX-Date
09/5/14
P/E TM
18.0x
Dividend
0.17
Dividend Yield
3.70%
Current Stock Chart for PHARMANIAGA BERHAD (PHRM)

Related News

No related news articles were found.

pharmaniaga berhad (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmaniaga berhad (PHRM) Details

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare company primarily in Malaysia and Indonesia. It operates through Logistics and Distribution, and Manufacturing segments. The company is involved in the manufacture and sale of generic pharmaceutical products; supply, trading, and installation of medical and hospital equipment; trading and wholesale of consumer products; and distribution and trading of pharmaceutical products, medical products, food supplements, and diagnostic products. It also conducts research and development of pharmaceutical products, as well as provides hospital equipping services. The company is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.

pharmaniaga berhad (PHRM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmaniaga berhad (PHRM) Key Developments

Pharmaniaga Bhd Declares Second Interim Dividend for the Year Ending December 31, 2014, Payable on September 24, 2014; Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

For the second quarter, the Directors of Pharmaniaga Bhd have declared a second interim dividend of 4.00 sen per share in respect of the year ending December 31, 2014. The dividend will be paid on September 24, 2014 to shareholders registered in the Register of Members at the close of business on September 9, 2014. The company reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported profit before taxation of MYR 24,622,000, profit of MYR 15,957,000 and profit attributable to owners of the parent of MYR 15,975,000 or 6.17 sen per basic share on revenue of MYR 525,072,000 against profit before taxation of MYR 9,605,000, profit of MYR 6,171,000 and profit attributable to owners of the parent of MYR 5,865,000 or 2.27 sen per basic share on revenue of MYR 437,633,000 a year ago period. For the six months, the company reported profit before taxation of MYR 62,781,000, profit of MYR 42,603,000 and profit attributable to owners of the parent of MYR 42,192,000 or 16.30 sen per basic share on revenue of MYR 993,744,000 against profit before taxation of MYR 46,529,000, profit of MYR 31,324,000 and profit attributable to owners of the parent of MYR 30,636,000 or 11.83 sen per basic share on revenue of MYR 937,972,000 a year ago period. Net cash used in operating activities was MYR 15,704,000 against net cash generated from operating activities of MYR 99,499,000 a year ago period. Purchase of property, plant and equipment was MYR 11,260,000 against MYR 15,922,000 a year ago. Purchase of intangible assets was MYR 3,407,000 against MYR 11,370,000 a year ago. The revenue for the six-month period increased 5.9%, on the back of stronger contributions from concession as well as non-concession business. Cumulatively, the group's PBT was higher compared with corresponding period last year, as a result of increased contributions from concession business.

Pharmaniaga Bhd Declares Second Interim Single Tier Dividend, Payable on September 24, 2014

Pharmaniaga Bhd declared a second interim single tier dividend of 4.00 Malaysian sen per share in respect of the year ended December 31, 2014. The dividend will be paid on September 24, 2014. The Ex-date is September 5, 2014 with entitlement date on September 9, 2014.

Pharmaniaga Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Pharmaniaga announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported profit attributable to owners of parent of MYR 26,217,000 or 10.13 sen basic earnings per share on revenue of MYR 468,672,000 compared to profit attributable to owners of parent of MYR 24,771,000 or 9.57 sen basic earnings per share on revenue of MYR 500,339,000 of prior year period. Profit before taxation was MYR 38,159,000 against MYR 36,924,000 of prior year period. Net cash used in operating activities was MYR 7,359,000 against cash generated from operating activities of MYR 41,825,000 of prior year period. Purchase of property, plant and equipment amounted to MYR 7,1490,00 against MYR 5,820,000 of prior year period. Purchase of intangible assets was MYR 194,000 against MYR 968,000 of prior year period.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:MK 4.65 MYR +0.01

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies
 

Industry Analysis

PHRM

Industry Average

Valuation PHRM Industry Range
Price/Earnings 17.6x
Price/Sales 0.6x
Price/Book 2.3x
Price/Cash Flow 15.3x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMANIAGA BERHAD, please visit www.pharmaniaga.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.